Impact BioMedical, Inc. (IBO)
NYSE: IBO · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2021
Who owns Impact BioMedical, Inc.
As filed with the SECHolders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
9
report now, of 10 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
Heng Fai Ambrose Chan
SCHEDULE 13D/A · filed Apr 4, 2025 · Common Stock · reported falling below 5%, from 16.9% in Apr 2, 2025
What IBO reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
DSS Pure Air INC
A company bought · acquisition · owns, named in the 10-K filed Mar 11, 2026
9 subsidiaries in 1 country, from the list filed with the 10-K filed Mar 11, 2026.
Insider tradesForm 4
3sales
0purchases
0sales on a scheduled plan
2people selling
$100,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 5, 2025 to Nov 5, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 5, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 13 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Macko Todd D | Chief Financial Officer | 2 | $0 | 0 | 0 | $0 |
| Grady Jason | director | 1 | $0 | 0 | 0 | $0 |
| Dss, Inc. | 10% owner | 3 | $0 | 0 | 0 | $0 |